Lifeboat Foundation

The virus is called monkeypox because researchers first detected it in laboratory monkeys in 1958, but it is thought to transmit to people from wild animals such as rodents or from other infected people. In an average year, a few thousand cases occur in Africa, typically in the western and central parts of the continent. But cases outside Africa have previously been limited to a handful that were associated with travel to Africa or with the importation of infected animals. The number of cases detected outside of Africa in the past week alone — which is almost certain to increase — has already surpassed the total number detected outside the continent since 1970, when the virus was first found to cause disease in humans. This rapid spread is what has scientists on high alert.

But monkeypox is no SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic, says Jay Hooper, a virologist at the US Army Medical Research Institute of Infectious Diseases in Fort Detrick, Maryland. It doesn’t transmit from person to person as readily, and because it is related to the smallpox virus, there are already treatments and vaccines on hand for curbing its spread. So although scientists are concerned — because any new viral behaviour is worrying — they are not panicked.

Unlike SARS-CoV-2, which spreads through tiny air-borne droplets called aerosols, monkeypox is thought to spread from close contact with bodily fluids, such as saliva from coughing. That means a person with monkeypox is likely to infect far fewer close contacts than someone with SARS-CoV-2, Hooper says. Both viruses can cause flu-like symptoms, but monkeypox also triggers enlarged lymph nodes and, eventually, distinctive fluid-filled lesions on the face, hands and feet. Most people recover from monkeypox in a few weeks without treatment.

The bottom of the ocean is full of mysteries but scientists have recently uncovered one of its best-kept secrets. For 25 years, drug hunters have been searching for the source of a natural chemical that had shown promise in initial studies for treating cancer. Now, researchers at University of Utah Health report that easy-to-find soft corals—flexible corals that resemble underwater plants—make the elusive compound.

Identifying the source allowed the researchers to go a step further and find the animal’s DNA code for synthesizing the chemical. By following those instructions, they were able to carry out the first steps of re-creating the soft coral chemical in the laboratory.

“This is the first time we have been able to do this with any drug lead on Earth,” says Eric Schmidt, Ph.D., professor of medicinal chemistry at U of U Health. He led the study with Paul Scesa, Ph.D., postdoctoral scientist and first author, and Zhenjian Lin, Ph.D., assistant research professor.

Researchers have discovered that Clostridium septicum rapidly kills cells by releasing a toxin that punches holes in the surface of the cell. This induces an immune response that can lead to sepsis and shock. The team is now exploring whether it’s possible to develop drugs to neutralize the toxin to treat the infection.

T cells that attack apolipoprotein B, the main component of “bad” cholesterol, could be contributing to inflammation that worsens heart disease.

Cell-Based Dairy Bio-Products For Health & Nutrition — Dr. Aletta Schnitzler, Ph.D. — CSO — Turtletree Labs

Dr. Aletta Schnitzler, PhD. is the Chief Scientific Officer at TurtleTree Labs (https://turtletree.com/) where she leads the R&D teams and spearheads an innovation roadmap to bring nutritious cell-based dairy and meat alternatives to market.

Continue reading “Dr Aletta Schnitzler — CSO — TurtleTree Labs — Cell-Based Dairy Bio-Products For Health & Nutrition” »

Summary: Study reveals the ZNF117 gene is a major regulator of glioblastoma tumor cells.

Source: Yale.

A recent research paper published in Nature Communications by a team led by Yale School of Medicine researchers finds a promising way to make brain cancer cells more susceptible to chemotherapy.

A mechanism that causes autism, schizophrenia, Alzheimer’s and other conditions and is shared by mutations in the genes ADNP and SHANK3 has been unraveled by Tel Aviv University researchers who developed an experimental drug they found to be effective in animal models.

The drug could also be suitable for treating a range of rare syndromes that impair brain functions, said the scientists. The researchers were led by Prof. Illana Gozes from the Department of Human Molecular Genetics and Biochemistry at TAU’s Sackler Faculty of Medicine and the Sagol School of Neuroscience. The experimental drug, called Davunetide, had previously been developed in her lab.

The paper, which the team called a “scientific breakthrough,” was published in the scientific journal Molecular Psychiatry under the title “SH3-and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism.”

A total lunar eclipse is an incredible sight. As Earth passes between the Moon and the Sun, its shadow slips across the face of our satellite so only long, red wavelengths – sunlight refracted by Earth’s atmosphere – can slip through, tinting the usually pale Moon blood-red.

That’s when we see it from here, on our planet. But from space, the view is very different – and now we can see what that looks like, thanks to the asteroid probe Lucy, led by the Southwest Research Institute (SwRI), launched in October 2021.

Continue reading “A Spacecraft Just Recorded The Lunar Eclipse Like You’ve Never Witnessed It Before” »